Working… Menu
Trial record 4 of 16 for:    immunitor

Open Label Trial of Immunotherapy for Advanced Liver Cancer (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02256514
Recruitment Status : Enrolling by invitation
First Posted : October 3, 2014
Last Update Posted : August 30, 2019
Immunitor Inc.
Information provided by (Responsible Party):
Immunitor LLC

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : December 2019